Postsplenectomy course in homozygous sickle cell disease

Area of Science:

• Pediatric Hematology
• Sickle Cell Disease Management
• Surgical Outcomes

Background:

• Splenectomy is a treatment option for certain complications of sickle cell (SS) disease, such as splenic sequestration and hypersplenism.
• Concerns exist regarding the increased risk of infection and mortality following splenectomy in children with SS disease.

Purpose of the Study:

• To evaluate the long-term risks of death, overwhelming septicemia, and other complications in children with sickle cell (SS) disease who have undergone splenectomy.
• To compare outcomes between splenectomy patients and a matched control group.

Main Methods:

• A retrospective review of 130 patients with SS disease who underwent splenectomy over 22.5 years was conducted.
• Patients were compared to a matched control group for sex, age, and follow-up duration.
• Outcomes analyzed included mortality, bacteremia, painful crises, acute chest syndromes, and febrile episodes.

Main Results:

• No significant difference in mortality or bacteremic episodes was observed between the splenectomy and control groups.
• Patients who underwent splenectomy experienced more frequent painful crises and acute chest syndromes compared to controls.
• Acute chest syndrome was more prevalent in patients with a history of acute splenic sequestration.

Conclusions:

• Splenectomy in children with sickle cell (SS) disease does not elevate the risk of death or bacteremic illness.
• The procedure should not be postponed if indicated due to concerns about mortality or bacteremia.
• Increased vigilance for painful crises and acute chest syndromes is warranted post-splenectomy.